BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30212830)

  • 1. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy.
    Liu F; Zhang S; Xu R; Gao S; Yin J
    Kidney Blood Press Res; 2018; 43(5):1425-1436. PubMed ID: 30212830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.
    Peng H; Li Y; Wang C; Zhang J; Chen Y; Chen W; Cao J; Wang Y; Hu Z; Lou T
    Sci Rep; 2016 Feb; 6():20304. PubMed ID: 26842599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum response factor induces endothelial-mesenchymal transition in glomerular endothelial cells to aggravate proteinuria in diabetic nephropathy.
    Zhao L; Zhao J; Wang X; Chen Z; Peng K; Lu X; Meng L; Liu G; Guan G; Wang F
    Physiol Genomics; 2016 Oct; 48(10):711-718. PubMed ID: 27565710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
    Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
    PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy.
    Guan G; Xie J; Dai Y; Han H
    J Biol Chem; 2022 Mar; 298(3):101725. PubMed ID: 35157852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 promotes endothelial-to-mesenchymal transition of glomerular endothelial cells via MEK/ERK signaling pathway in diabetic nephropathy.
    Shang J; Zhang Y; Jiang Y; Li Z; Duan Y; Wang L; Xiao J; Zhao Z
    Biochem Biophys Res Commun; 2017 Mar; 484(2):435-441. PubMed ID: 28137583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiated embryonic chondrocyte gene 2 (DEC2) inhibits transdifferentiation of mouse glomerular endothelial cells and renal fibrosis by blocking TGF-β/ROCK1 signaling pathway].
    Yin X; Chen L; Meng F; Jiang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Sep; 39(9):816-823. PubMed ID: 37732577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
    Correia AC; Moonen JR; Brinker MG; Krenning G
    J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes.
    Yasuzawa T; Nakamura T; Ueshima S; Mima A
    J Diabetes Res; 2021; 2021():2182225. PubMed ID: 34977254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase promotes endothelial-to-mesenchymal transition in diabetic glomerular endothelial cells through mediating ERK signaling.
    Chang K; Xie Q; Niu J; Gu Y; Zhao Z; Li F; Qin Q; Liu X
    Cell Death Discov; 2022 Feb; 8(1):67. PubMed ID: 35173145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
    Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
    Zhang H; Hu J; Liu L
    Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy.
    Lu L; Zhong Z; Gu J; Nan K; Zhu M; Miao C
    Mol Med; 2021 Jul; 27(1):74. PubMed ID: 34238215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats.
    Wu G; Tu Y; Jia R
    Biomed Pharmacother; 2010 Feb; 64(2):124-9. PubMed ID: 20006464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
    Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
    Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
    Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
    Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell.
    Yu CH; Suriguga ; Gong M; Liu WJ; Cui NX; Wang Y; Du X; Yi ZC
    Exp Mol Pathol; 2017 Jun; 102(3):377-383. PubMed ID: 28347704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability.
    Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D
    Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.